secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75496 grounded facts newest July 17, 2026, 5:30 PM ET RSS · JSON

Showing 9701–9750 of 18437

Departed

Donald Marvin

Chief Financial Officer
CMMB · Chemomab Therapeutics Ltd.
Effective
2023-06-01
Successor
Sigal Fattal
Filed
June 5, 2023, 7:59 PM ET
the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.
Appointed

Joy Bruce

principal financial and accounting officer
Rain Oncology Inc.
Effective
2023-06-01
Filed
June 5, 2023, 7:59 PM ET
Joy Bruce, the Company’s Director of Accounting, assumed the role of the Company’s principal financial and accounting officer, effective as of such date.
Appointed

Karim Donnez

Chief Executive Officer
LVWR · LiveWire Group, Inc.
Effective
2023-06-12
Filed
June 5, 2023, 7:59 PM ET
On June 5, 2023, LiveWire Group, Inc. (the “Company”) announced that the Board of Directors appointed Karim Donnez as the Company’s Chief Executive Officer, effective June 12, 2023.
Role change (interim)

James Clavijo

interim Chief Financial Officer
LGVN · Longeveron Inc.
Effective
2023-06-10
Filed
June 5, 2023, 7:59 PM ET
Mr. Clavijo will continue in the role of interim Chief Financial Officer beyond June 9, 2023, pursuant to the terms of a Consulting Agreement entered into by and between the Company and Mr. Clavijo, effective June 10, 2023
Appointed

Neeraj Jain

Chief Financial Officer
Startek, Inc.
Effective
2023-06-01
Filed
June 5, 2023, 7:59 PM ET
On June 1, 2023, the Company announced the appointment of Mr. Neeraj Jain, age 46, as Chief Financial Officer.
Departed

Nishit Shah

Chief Financial Officer
Startek, Inc.
Effective
2023-06-02
Successor
Neeraj Jain
Filed
June 5, 2023, 7:59 PM ET
On May 30, 2023, Nishit Shah gave notice of his intention to resign from his position as Chief Financial Officer of StarTek, Inc.
Role change

Ryan L. Smith

Chief Financial Officer
USEG · US ENERGY CORP
Effective
2023-06-01
Successor
Mark Zajac
Filed
June 5, 2023, 7:59 PM ET
Effective as of his appointment as CFO, Mr. Ryan L. Smith, the Chief Executive Officer and director of the Company, ceased serving as Chief Financial Officer and Principal Financial and Accounting Officer of the Company.
Appointed

Mark Zajac

Chief Financial Officer
USEG · US ENERGY CORP
Effective
2023-06-01
Successor
Ryan L. Smith
Filed
June 5, 2023, 7:59 PM ET
On, and effective on, June 1, 2023, the Board of Directors, with the recommendation of the Nominating Committee of the Board of Directors, of U.S. Energy Corp. (the “ Company ”, “ we ” and “ us ”), appointed Mr. Mark Zajac, as the Chief Financial Officer (CFO) and Principal Financial and Accounting Officer of the Company.
Departed

Andrew Taylor

Chief Financial Officer
Motus GI Holdings, Inc.
Effective
2023-06-02
Successor
Ravit Ram
Filed
June 5, 2023, 7:59 PM ET
On May 30, 2023, Motus GI Holdings, Inc. (the “Company”) received notice of the resignation of Andrew Taylor as the Company’s Chief Financial Officer, and all other positions held at the Company, effective June 2, 2023.
Appointed

Ravit Ram

Chief Financial Officer
Motus GI Holdings, Inc.
Effective
2023-06-02
Filed
June 5, 2023, 7:59 PM ET
Effective as of June 2, 2023, the Company’s Board of Directors (the “Board”) accepted Mr. Taylor’s resignation as Chief Financial Officer and all other positions held at the Company, and appointed Ravit Ram, 49, as the Company’s Chief Financial Officer.
Departed

Scott Scheirman

President and Chief Executive Officer
PMTS · CPI Card Group Inc.
Effective
2024-02-28
Filed
June 5, 2023, 7:59 PM ET
On May 31, 2023, Scott Scheirman, the Company’s President and Chief Executive Officer, notified the Company of his intent to retire from the Company in order to have more time for family.
Departed

Jaylvin Chan Yee Fei

Chief Financial Officer
TGL · TREASURE GLOBAL INC
Effective
2023-07-31
Successor
Chan Meng Chun
Filed
June 5, 2023, 7:59 PM ET
On May 31, 2023, Treasure Global Inc (the "Company") received a resignation notice from its Chief Financial Officer, Jaylvin Chan Yee Fei who served as the Company’s principal financial officer and principal accounting officer. Such resignation will be effective on July 31, 2023.
Appointed

Chan Meng Chun

Chief Financial Officer
TGL · TREASURE GLOBAL INC
Effective
2023-07-31
Filed
June 5, 2023, 7:59 PM ET
On June 5, 2023, the Company’s Board of Directors appointed Chan Meng Chun, age 51, as the Company’s Chief Financial Officer, effective July 31, 2023
Appointed

Christopher Meinerz

Chief Financial Officer
ALPINE 4 HOLDINGS, INC.
Effective
2023-05-30
Filed
June 5, 2023, 7:59 PM ET
appointed Christopher Meinerz to serve as Chief Financial Officer of the Company.
Departed

Filippo "Peter" Caldini

Chief Executive Officer
Acreage Holdings, Inc.
Effective
2023-06-30
Successor
Dennis Curran
Filed
June 5, 2023, 7:59 PM ET
On June 2, 2023, Filippo “Peter” Caldini provided notice of his resignation as Chief Executive Officer of Acreage Holdings, Inc. (the “Company” or “Acreage”), effective June 30, 2023.
Appointed

Dennis Curran

Chief Executive Officer
Acreage Holdings, Inc.
Effective
2023-07-01
Filed
June 5, 2023, 7:59 PM ET
The Board has appointed Dennis Curran, the Company’s current Chief Operating Officer, as the Chief Executive Officer of Acreage, effective July 1, 2023.
Appointed

David Hayes

Chief Financial Officer
LDI · loanDepot, Inc.
Effective
2023-06-26
Filed
June 5, 2023, 7:59 PM ET
David Hayes has been appointed as Chief Financial Officer of the Company, effective June 26, 2023
Appointed

Dr. Torsten Hombeck

Chief Financial Officer
AWHL · Aspira Women's Health Inc.
Effective
2023-06-15
Filed
June 2, 2023, 7:59 PM ET
As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.
Departed (interim)

Marlene McLennan

Interim Chief Financial Officer
AWHL · Aspira Women's Health Inc.
Effective
2023-05-31
Successor
Dr. Torsten Hombeck
Filed
June 2, 2023, 7:59 PM ET
Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.
Departed

Scott Praill

Chief Financial Officer
HURA · TuHURA Biosciences, Inc./NV
Effective
2023-05-31
Successor
Robert E. Hoffman
Filed
June 2, 2023, 7:59 PM ET
On May 30, 2023, Scott Praill resigned from his position as Chief Financial Officer of Kintara Therapeutics, Inc. (the “Company”), effective May 31, 2023.
Appointed (interim)

Robert E. Hoffman

interim Chief Financial Officer
HURA · TuHURA Biosciences, Inc./NV
Effective
2023-06-01
Filed
June 2, 2023, 7:59 PM ET
On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Robert E. Hoffman, the current President, Chief Executive Officer, and Chairman of the Board of the Company, to succeed Mr. Praill as the Company’s interim Chief Financial Officer.
Appointed

Eric Johnson

Chief Executive Officer
MOMENTIVE GLOBAL INC.
Effective
2023-06-01
Filed
June 2, 2023, 7:59 PM ET
Eric Johnson has been appointed as CEO of the Company effective June 1, 2023.
Departed

Alexander Lurie

Chief Executive Officer
MOMENTIVE GLOBAL INC.
Effective
2023-06-01
Successor
Eric Johnson
Filed
June 2, 2023, 7:59 PM ET
Effective June 1, 2023, Alexander Lurie is stepping down as the Company’s Chief Executive Officer (“CEO”) and Priyanka Carr is stepping down as the Company’s Chief Operating Officer (“COO”).
Appointed

Brian Piekos

Chief Financial Officer
ELTX · Elicio Therapeutics, Inc.
Effective
2023-06-01
Filed
June 2, 2023, 7:59 PM ET
Brian Piekos 48 Chief Financial Officer
Departed

Gregory S. Curhan

Chief Financial Officer
ELTX · Elicio Therapeutics, Inc.
Effective
2023-06-01
Successor
Brian Piekos
Filed
June 2, 2023, 7:59 PM ET
(ii) each of Gregory S. Curhan, Angion’s Chief Financial Officer and Jay R. Venkatesan, M.D., were terminated as employees of the Company effective as of the effective time of the Merger.
Appointed

Robert Connelly

Chief Executive Officer, President and Class I Director
ELTX · Elicio Therapeutics, Inc.
Effective
2023-06-01
Filed
June 2, 2023, 7:59 PM ET
Robert Connelly 63 Chief Executive Officer, President and Class I Director
Departed

Karl F. Krebs

Chief Financial Officer and Treasurer
CHMG · CHEMUNG FINANCIAL CORP
Effective
2023-06-30
Successor
Dale M. McKim III
Filed
June 2, 2023, 7:59 PM ET
Mr. McKim succeeds Karl F. Krebs who will retire as Chief Financial Officer and Treasurer of the Corporation, and Executive Vice President, Chief Financial Officer and Treasurer of the Bank effective June 30, 2023.
Appointed

Dale M. McKim III

Chief Financial Officer and Treasurer
CHMG · CHEMUNG FINANCIAL CORP
Effective
2023-07-01
Filed
June 2, 2023, 7:59 PM ET
appointed Dale M. McKim III, age 48, Chief Financial Officer and Treasurer of the Corporation, and Executive Vice President, Chief Financial Officer and Treasurer of the Bank effective July 1, 2023.
Appointed

David M. Urso

President and Chief Executive Officer
LITS · Lite Strategy, Inc.
Effective
2023-06-02
Filed
June 2, 2023, 7:59 PM ET
On May 31, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) appointed David M. Urso to be President and Chief Executive Officer (“CEO”) of the Company, effective as of June 2, 2023
Departed

Daniel Gold

President and Chief Executive Officer
LITS · Lite Strategy, Inc.
Effective
2023-06-02
Successor
David M. Urso
Filed
June 2, 2023, 7:59 PM ET
terminated the employment of Daniel Gold, Ph.D., the current President and CEO, effective as of June 2, 2023
Role change

Christopher D. Wampler

Vice President, Chief Financial Officer, Controller and Treasurer
DCO · DUCOMMUN INC /DE/
Effective
2023-05-03
Filed
June 2, 2023, 7:59 PM ET
On May 3, 2023, Ducommun Incorporated, a Delaware corporation (the “Company”), reported that Christopher D. Wampler, Vice President, Chief Financial Officer, Controller and Treasurer, ceased to serve in that role but would continue his employment with the Company in a non-executive capacity.
Appointed

Heather Dixon

Chief Financial Officer
ACHC · Acadia Healthcare Company, Inc.
Effective
2023-07-10
Filed
June 2, 2023, 7:59 PM ET
On June 1, 2023, Acadia Healthcare Company, Inc. (the “Company”) appointed Heather Dixon as the Chief Financial Officer of the Company, effective July 10, 2023.
Appointed

Pantelis Dimitriou

Chief Financial Officer
Zalatoris Acquisition Corp.
Effective
2023-06-02
Filed
June 2, 2023, 7:59 PM ET
Pantelis Dimitriou was appointed as the Company’s Chief Financial Officer
Appointed

Paul Davis

Chief Executive Officer
Zalatoris Acquisition Corp.
Effective
2023-06-02
Filed
June 2, 2023, 7:59 PM ET
Paul Davis was appointed as Chief Executive Officer of the Company
Departed

Salman H. Khan

Chief Financial Officer
TONX · TON Strategy Co
Effective
2023-06-13
Successor
Bill J. Rivard
Filed
June 2, 2023, 7:59 PM ET
On May 30, 2023, Salman H. Khan provided notice of his decision to resign as Chief Financial Officer of Verb Technology Company, Inc. (the “Company”), effective June 13, 2023.
Appointed (interim)

Bill J. Rivard

Interim Chief Financial Officer
TONX · TON Strategy Co
Effective
2023-06-13
Filed
June 2, 2023, 7:59 PM ET
The Board of Directors (the “Board”) of the Company approved, effective as of June 13, 2023, the appointment of Bill J.Rivard, the current Corporate Controller, as Interim Chief Financial Officer of the Company.
Departed

Richard Fair

President and Chief Executive Officer
BELLICUM PHARMACEUTICALS, INC
Effective
2023-06-30
Filed
June 2, 2023, 7:59 PM ET
On May 31, 2023, the Company provided notices to Richard Fair, President and Chief Executive Officer, and Charity Scripture, Chief Development Officer that their employment by the Company will terminate on June 30, 2023.
Appointed

Christopher Meinerz

Chief Financial Officer
ALPINE 4 HOLDINGS, INC.
Effective
2023-05-30
Filed
June 2, 2023, 7:59 PM ET
appointed Christopher Meinerz to serve as Chief Financial Officer of the Company.
Departed

Matt Aune

Chief Financial Officer
PHUN · Phunware, Inc.
Effective
2023-06-02
Successor
Troy Reisner
Filed
June 2, 2023, 7:59 PM ET
On June 2, 2023, Phunware, Inc. (the "Company") announced that Matt Aune would be leaving his role as Chief Financial Officer, effective as of June 2, 2023
Appointed

Troy Reisner

Chief Financial Officer
PHUN · Phunware, Inc.
Effective
2023-06-02
Filed
June 2, 2023, 7:59 PM ET
The Company also announced the appointment of Troy Reisner as the Company’s Chief Financial Officer, also effective as of the Transition Date.
Departed

Anthony Camarda

Chief Financial Officer, Treasurer and Secretary
FWDI · Forward Industries, Inc.
Effective
2023-07-01
Successor
Kathleen Weisberg
Filed
June 2, 2023, 7:59 PM ET
the Board appointed Kathleen Weisberg as the Company’s Chief Financial Officer, Treasurer and Secretary, replacing Mr. Anthony Camarda in each such role, effective July 1, 2023.
Appointed

Kathleen Weisberg

Chief Financial Officer, Treasurer and Secretary
FWDI · Forward Industries, Inc.
Effective
2023-07-01
Filed
June 2, 2023, 7:59 PM ET
the Board appointed Kathleen Weisberg as the Company’s Chief Financial Officer, Treasurer and Secretary, replacing Mr. Anthony Camarda in each such role, effective July 1, 2023.
Departed

G. Alejandro Huerta

Chief Financial Officer
FLXS · FLEXSTEEL INDUSTRIES INC
Effective
2023-05-26
Successor
Derek P. Schmidt
Filed
June 1, 2023, 7:59 PM ET
On May 26, 2023, G. Alejandro Huerta, Chief Financial Officer and Principal Financial and Accounting Officer of the Company, submitted his resignation to pursue another opportunity.
Appointed (interim)

Derek P. Schmidt

Chief Financial Officer
FLXS · FLEXSTEEL INDUSTRIES INC
Effective
2023-05-30
Filed
June 1, 2023, 7:59 PM ET
Derek P. Schmidt, Chief Operating Officer, was appointed by the Board of Directors on May 30, 2023 to also serve in the roles of Chief Financial Officer and Principal Financial and Accounting Officer on an interim basis until a successor for Mr. Huerta is named.
Departed

John G. Sznewajs

Vice President, Chief Financial Officer
MAS · MASCO CORP /DE/
Effective
2023-05-31
Filed
June 1, 2023, 7:59 PM ET
Masco Corporation (the “Company”) entered into an agreement dated May 31, 2023 with John G. Sznewajs, the Company’s Vice President, Chief Financial Officer, in connection with his previously announced retirement from the Company on May 31, 2023.
Departed (interim)

Kate Burke

Chief Financial Officer
AB · ALLIANCEBERNSTEIN HOLDING L.P.
Effective
2023-05-31
Successor
William R. Siemers
Filed
June 1, 2023, 7:59 PM ET
On May 31, 2023, Kate Burke notified AllianceBernstein Holding L.P. (“AB”) of her resignation from her positions as Chief Operating Officer and Chief Financial Officer, effective May 31, 2023, to become the president of a large privately-owned asset management firm.
Appointed (interim)

William R. Siemers

Interim Chief Financial Officer
AB · ALLIANCEBERNSTEIN HOLDING L.P.
Effective
2023-06-01
Filed
June 1, 2023, 7:59 PM ET
AB appointed William R. Siemers, AB's Controller and Chief Accounting Officer, as Interim Chief Financial Officer, effective immediately.
Appointed

Bruce Chung

Executive Vice President and Chief Financial Officer
NRG · NRG ENERGY, INC.
Effective
2023-06-01
Filed
June 1, 2023, 7:59 PM ET
On May 31, 2023, Bruce Chung, age 49, was appointed Executive Vice President and Chief Financial Officer of NRG Energy, Inc. (the “Company”), effective June 1, 2023.
Departed

Alberto Fornaro

Chief Financial Officer
NRG · NRG ENERGY, INC.
Effective
2023-06-01
Successor
Bruce Chung
Filed
June 1, 2023, 7:59 PM ET
Effective June 1, 2023, Mr. Alberto Fornaro transitioned from Chief Financial Officer and from his positions with the Company and its subsidiaries.
Departed

Garry Menzel

President and Chief Executive Officer
TCR2 THERAPEUTICS INC.
Effective
2023-06-01
Filed
June 1, 2023, 7:59 PM ET
Garry Menzel, TCR 2 ’s President and Chief Executive Officer, resigned from his position as an officer of TCR 2

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.